| Primary |
| Drug Use For Unknown Indication |
33.1% |
| Unevaluable Event |
18.9% |
| Subarachnoid Haemorrhage |
13.5% |
| Hypertension |
8.8% |
| Product Used For Unknown Indication |
4.1% |
| Brain Operation |
2.7% |
| Cerebral Haemorrhage |
2.0% |
| Cerebral Infarction |
2.0% |
| Therapeutic Embolisation |
2.0% |
| Vasospasm |
2.0% |
| Anaemia |
1.4% |
| Constipation Prophylaxis |
1.4% |
| Dementia |
1.4% |
| Memory Impairment |
1.4% |
| Migraine |
1.4% |
| Vascular Test |
1.4% |
| Alcohol Abuse |
0.7% |
| Aneurysm Ruptured |
0.7% |
| Angiogram |
0.7% |
| Bipolar Disorder |
0.7% |
|
| Loss Of Consciousness |
10.3% |
| Syncope |
10.3% |
| Cardio-respiratory Arrest |
6.9% |
| Intracranial Hypotension |
6.9% |
| Acute Generalised Exanthematous Pustulosis |
5.2% |
| Eye Pain |
5.2% |
| Heart Rate Decreased |
5.2% |
| Incorrect Route Of Drug Administration |
5.2% |
| Respiratory Failure |
5.2% |
| Restlessness |
5.2% |
| Arrhythmia |
3.4% |
| Drug Effect Delayed |
3.4% |
| Gamma-glutamyltransferase Increased |
3.4% |
| Medication Error |
3.4% |
| Nervousness |
3.4% |
| Pain In Extremity |
3.4% |
| Pharmaceutical Product Complaint |
3.4% |
| Pyrexia |
3.4% |
| Rash Pustular |
3.4% |
| Respiratory Arrest |
3.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
48.4% |
| Product Used For Unknown Indication |
12.5% |
| Subarachnoid Haemorrhage |
9.4% |
| Pain |
4.7% |
| Urinary Tract Infection |
3.9% |
| Benign Prostatic Hyperplasia |
3.1% |
| Thrombosis Prophylaxis |
3.1% |
| Anaemia |
1.6% |
| Constipation Prophylaxis |
1.6% |
| Convulsion |
1.6% |
| Renal Hypertension |
1.6% |
| Secondary Hypertension |
1.6% |
| Vasospasm |
1.6% |
| Agitation |
0.8% |
| Alcohol Abuse |
0.8% |
| Constipation |
0.8% |
| Dyslipidaemia |
0.8% |
| Gastric Hypomotility |
0.8% |
| Gastroduodenal Ulcer |
0.8% |
| Hypertension |
0.8% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
30.8% |
| Gamma-glutamyltransferase Increased |
10.3% |
| Pancreatic Enzymes Increased |
10.3% |
| Subcorneal Pustular Dermatosis |
10.3% |
| Coma |
5.1% |
| Drug Effect Delayed |
5.1% |
| Respiratory Arrest |
5.1% |
| Haemorrhage |
2.6% |
| Incorrect Route Of Drug Administration |
2.6% |
| Liver Disorder |
2.6% |
| Pleural Effusion |
2.6% |
| Pyrexia |
2.6% |
| Subarachnoid Haemorrhage |
2.6% |
| Toxic Epidermal Necrolysis |
2.6% |
| Tracheostomy |
2.6% |
| Transaminases Increased |
2.6% |
|
| Concomitant |
| Parkinson's Disease |
29.6% |
| Hypertension |
19.2% |
| Product Used For Unknown Indication |
7.7% |
| Depression |
7.1% |
| Pain |
5.4% |
| Anxiety |
4.7% |
| Hypersensitivity |
4.7% |
| Constipation |
3.4% |
| Convulsion |
2.4% |
| Epilepsy |
2.0% |
| Nausea |
2.0% |
| Osteoporosis |
1.7% |
| Cardiac Failure |
1.3% |
| Colorectal Cancer |
1.3% |
| Diabetes Mellitus |
1.3% |
| Dizziness |
1.3% |
| Mydriasis |
1.3% |
| Peripheral Vascular Disorder |
1.3% |
| Asthma |
1.0% |
| Blood Pressure Increased |
1.0% |
|
| Diarrhoea |
17.5% |
| Stevens-johnson Syndrome |
12.3% |
| Coeliac Disease |
7.0% |
| Bone Pain |
5.3% |
| Microcytic Anaemia |
5.3% |
| Pancytopenia |
5.3% |
| Urinary Tract Infection |
5.3% |
| Weight Decreased |
5.3% |
| Cerebrovascular Accident |
3.5% |
| Hypertension |
3.5% |
| Hypoglycaemia |
3.5% |
| Neutropenia |
3.5% |
| Pneumonia |
3.5% |
| Pulmonary Embolism |
3.5% |
| Radiation Necrosis |
3.5% |
| Skin Fissures |
3.5% |
| Toxic Encephalopathy |
3.5% |
| Angina Pectoris |
1.8% |
| Brain Hypoxia |
1.8% |
| Cardiac Pacemaker Insertion |
1.8% |
|
